Previous close | 75.21 |
Open | 74.99 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 74.66 - 75.42 |
52-week range | 60.47 - 76.43 |
Volume | |
Avg. volume | 91,191 |
Market cap | N/A |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.36 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 71.90 |
As you might know, AstraZeneca PLC ( LON:AZN ) just kicked off its latest quarterly results with some very strong...
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
Fusion (FUSN) is expected to provide updates regarding the developmental program of its lead candidate, FPI-2265, for prostate cancer in the first-quarter earnings release.